Scipher to use proprietary patient molecular data analyzed by its SpectraTM platform to identify novel drug targets TARA Biosystems to progress selected targets in its BiowireTM II drug discovery platform forcardiac laminopathies. Partnership set to reduce target...
October 12, 2021, Atlanta, GA and Waltham, MA – Trellis Rx, a leading technology-enabled specialty pharmacy services provider, today announced the integration of PrismRA, a diagnostic blood test created by Scipher Medicine that predicts non-response to TNF...
SEPTEMBER 24, WALTHAM, MA – Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announces the appointment of Sam A. Davis, JD, as General Counsel. Sam will lead all legal matters, including strategic...
SEPTEMBER 16, 2021 – WALTHAM, MA Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced a partnership with Ventegra, Inc., a new class-of-trade Medical Benefits Manager that uses innovative...
Expanded intended use for the blood test validated in Network-004 study.Now, most rheumatoid arthritis patients can be tested at any point in their clinical journey.Test enables providers to identify optimal rheumatoid arthritis treatment for more than 600,000...
Blood Test Predicts TNFi Response in Patients Both Naïve to and Experienced with TherapyProviders Can Access Patient-Specific Data for Optimized Therapy Selection JUNE 24, 2021 – WALTHAM, MA – Scipher Medicine, a precision immunology company matching...
